Terms: = Uterine cancer AND CD74, ENSG00000019582, 972, protein 41, Ia-GAMMA, HLADG, DHLAG AND Treatment
11 results:
1. Comorbidities of Keloid and Hypertrophic Scars Among Participants in UK Biobank.
Ung CY; Warwick A; Onoufriadis A; Barker JN; Parsons M; McGrath JA; Shaw TJ; Dand N
JAMA Dermatol; 2023 Feb; 159(2):172-181. PubMed ID: 36598763
[TBL] [Abstract] [Full Text] [Related]
2. Identification of novel prognosis-related genes in the endometrial cancer immune microenvironment.
Ma J; Zhang JK; Yang D; Ma XX
Aging (Albany NY); 2020 Nov; 12(21):22152-22173. PubMed ID: 33159014
[TBL] [Abstract] [Full Text] [Related]
3. Importance of Technique, Target Selection, Contouring, Dose Prescription, and Dose-Planning in External Beam Radiation Therapy for Cervical cancer: Evolution of Practice From EMBRACE-I to II.
Berger T; Seppenwoolde Y; Pötter R; Assenholt MS; Lindegaard JC; Nout RA; de Leeuw A; Jürgenliemk-Schulz I; Tan LT; Georg D; Kirisits C; Dumas I; Nesvacil N; Swamidas J; Hudej R; Lowe G; Hellebust TP; Menon G; Fokdal L; Tanderup K;
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):885-894. PubMed ID: 30904706
[TBL] [Abstract] [Full Text] [Related]
4. Gene signature based on degradome-related genes can predict distal metastasis in cervical cancer patients.
Fernandez-Retana J; Zamudio-Meza H; Rodriguez-Morales M; Pedroza-Torres A; Isla-Ortiz D; Herrera L; Jacobo-Herrera N; Peralta-Zaragoza O; López-Camarillo C; Morales-Gonzalez F; Cantu de Leon D; Pérez-Plasencia C
Tumour Biol; 2017 Jun; 39(6):1010428317711895. PubMed ID: 28639897
[TBL] [Abstract] [Full Text] [Related]
5. Gene expression changes in residual advanced cervical cancer after radiotherapy: indicators of poor prognosis and radioresistance?
Fu ZC; Wang FM; Cai JM
Med Sci Monit; 2015 May; 21():1276-87. PubMed ID: 25940978
[TBL] [Abstract] [Full Text] [Related]
6. Factors associated with cancer-specific and overall survival among Indigenous and non-Indigenous gynecologic cancer patients in Queensland, Australia: a matched cohort study.
Diaz A; Moore SP; Martin JH; Green AC; Garvey G; Valery PC
Int J Gynecol Cancer; 2015 Mar; 25(3):542-7. PubMed ID: 25700033
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic factors and clinical outcome of patients with recurrent early-stage epithelial ovarian cancer: an Italian multicenter retrospective study.
Gadducci A; Cosio S; Zola P; Sostegni B; Fuso L; Sartori E
Int J Gynecol Cancer; 2013 Mar; 23(3):461-8. PubMed ID: 23370604
[TBL] [Abstract] [Full Text] [Related]
8. Defining prognostic variables in recurrent endometrioid endometrial cancer: a 15-year single-institution review.
Esselen KM; Boruta DM; del Carmen M; Schorge JO; Goodman A; Growdon WB
Int J Gynecol Cancer; 2011 Aug; 21(6):1078-83. PubMed ID: 21633304
[TBL] [Abstract] [Full Text] [Related]
9. [Study on high risk factors associated with positive margin of cervix conization in patient with cervical intraepithelial neoplasia].
Lu HX; Chen YX; Ni J; Wan XY; Lü WG; Xie X
Zhonghua Fu Chan Ke Za Zhi; 2009 Mar; 44(3):200-3. PubMed ID: 19570446
[TBL] [Abstract] [Full Text] [Related]
10. A multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids. The HOPEFUL study.
Hirst A; Dutton S; Wu O; Briggs A; Edwards C; Waldenmaier L; Maresh M; Nicholson A; McPherson K
Health Technol Assess; 2008 Mar; 12(5):1-248, iii. PubMed ID: 18331704
[TBL] [Abstract] [Full Text] [Related]
11. Large cell neuroendocrine carcinoma of the uterine cervix: a clinicopathological study of six cases.
Sato Y; Shimamoto T; Amada S; Asada Y; Hayashi T
Int J Gynecol Pathol; 2003 Jul; 22(3):226-30. PubMed ID: 12819387
[TBL] [Abstract] [Full Text] [Related]
